Skip to content
LexBuild

Importer of Controlled Substances Registration: United States Pharmacopeial Convention

---
identifier: "/us/fr/2015-30552"
source: "fr"
legal_status: "authoritative_unofficial"
title: "Importer of Controlled Substances Registration: United States Pharmacopeial Convention"
title_number: 0
title_name: "Federal Register"
section_number: "2015-30552"
section_name: "Importer of Controlled Substances Registration: United States Pharmacopeial Convention"
positive_law: false
currency: "2015-12-03"
last_updated: "2015-12-03"
format_version: "1.1.0"
generator: "[email protected]"
agency: "Justice Department"
document_number: "2015-30552"
document_type: "notice"
publication_date: "2015-12-03"
agencies:
  - "Justice Department"
  - "Drug Enforcement Administration"
fr_citation: "80 FR 75689"
fr_volume: 80
docket_ids:
  - "Docket No. DEA-392"
fr_action: "Notice of registration."
---

#  Importer of Controlled Substances Registration: United States Pharmacopeial Convention

**ACTION:**

Notice of registration.

**SUMMARY:**

United States Pharmacopeial Convention applied to be registered as an importer of certain basic classes of controlled substances. The Drug Enforcement Administration (DEA) grants United States Pharmacopeial Convention registration as an importer of those controlled substances.

**SUPPLEMENTARY INFORMATION:**

By notice dated June 25, 2015, and published in the *Federal Register* on July 6, 2015, 80 FR 38466, United States Pharmacopeial Convention, 12601 Twinbrook Parkway, Rockville, Maryland 20852 applied to be registered as an importer of certain basic classes of controlled substances. No comments or objections were submitted for this notice.

The DEA has considered the factors in 21 U.S.C. 823, 952(a) and 958(a) and determined that the registration of United States Pharmacopeial Convention to import the basic classes of controlled substances is consistent with the public interest and with United States obligations under international treaties, conventions, or protocols in effect on May 1, 1971. The DEA investigated the company's maintenance of effective controls against diversion by inspecting and testing the company's physical security systems, verifying the company's compliance with state and local laws, and reviewing the company's background and history.

Therefore, pursuant to 21 U.S.C. 952(a) and 958(a), and in accordance with 21 CFR 1301.34, the above-named company is granted registration as an importer of the basic classes of controlled substances:

| Controlled substance | Schedule |
| --- | --- |
| Cathinone (1235) | I |
| Methaqualone (2565) | I |
| Lysergic acid diethylamide (7315) | I |
| Marihuana (7360) | I |
| Tetrahydrocannabinols (7370) | I |
| 4-Methyl-2,5-dimethoxyamphetamine (7395) | I |
| 3,4-Methylenedioxyamphetamine (7400) | I |
| Codeine-N-oxide (9053) | I |
| Difenoxin (9168) | I |
| Heroin (9200) | I |
| Morphine-N-oxide (9307) | I |
| Norlevorphanol (9634) | I |
| Amphetamine (1100) | II |
| Methamphetamine (1105) | II |
| Phenmetrazine (1631) | II |
| Methylphenidate (1724) | II |
| Amobarbital (2125) | II |
| Pentobarbital (2270) | II |
| Secobarbital (2315) | II |
| Glutethimide (2550) | II |
| Phencyclidine (7471) | II |
| 4-Anilino-N-phenethyl-4-piperidine (ANPP) (8333) | II |
| Phenylacetone (8501) | II |
| Alphaprodine (9010) | II |
| Anileridine (9020) | II |
| Cocaine (9041) | II |
| Codeine (9050) | II |
| Dihydrocodeine (9120) | II |
| Oxycodone (9143) | II |
| Hydromorphone (9150) | II |
| Diphenoxylate (9170) | II |
| Hydrocodone (9193) | II |
| Levomethorphan (9210) | II |
| Levorphanol (9220) | II |
| Meperidine (9230) | II |
| Methadone (9250) | II |
| Dextropropoxyphene, bulk (non-dosage forms) (9273) | II |
| Morphine (9300) | II |
| Thebaine (9333) | II |
| Oxymorphone (9652) | II |
| Noroxymorphone (9668) | II |
| Alfentanil (9737) | II |
| Sufentanil (9740) | II |

The company plans to import the listed controlled substances in bulk powder form from foreign sources for the manufacture of analytical reference standards for sale to their customers.

The company plans to import analytical reference standards for distribution to its customers for research and analytical purposes. Placement of these drug codes onto the company's registration does not translate into automatic approval of subsequent permit applications to import controlled substances. Approval of permit applications will occur only when the registrant's business activity is consistent with what is authorized under to 21 U.S.C 952(a)(2). Authorization will not extend to the import of FDA approved or non-approved finished dosage forms for commercial sale.

Dated: November 23, 2015.

Louis J. Milione,

Deputy Assistant Administrator.